Cargando…
Neuronal Cytoskeleton in Intellectual Disability: From Systems Biology and Modeling to Therapeutic Opportunities
Intellectual disability (ID) is a pathological condition characterized by limited intellectual functioning and adaptive behaviors. It affects 1–3% of the worldwide population, and no pharmacological therapies are currently available. More than 1000 genes have been found mutated in ID patients pointi...
Autores principales: | Liaci, Carla, Camera, Mattia, Caslini, Giovanni, Rando, Simona, Contino, Salvatore, Romano, Valentino, Merlo, Giorgio R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201358/ https://www.ncbi.nlm.nih.gov/pubmed/34200511 http://dx.doi.org/10.3390/ijms22116167 |
Ejemplares similares
-
The Emerging Roles of Long Non-Coding RNAs in Intellectual Disability and Related Neurodevelopmental Disorders
por: Liaci, Carla, et al.
Publicado: (2022) -
Rho GTPases in Intellectual Disability: From Genetics to Therapeutic Opportunities
por: Zamboni, Valentina, et al.
Publicado: (2018) -
Self-Determination in People with Intellectual Disability: The Mediating Role of Opportunities
por: Vicente, Eva, et al.
Publicado: (2020) -
Pharmacogenomics: an opportunity for personalised psychotropic prescribing in adults with intellectual disabilities
por: Perera, Bhathika, et al.
Publicado: (2022) -
Genetics and Clinical Neuroscience in Intellectual Disability
por: Romano, Corrado
Publicado: (2022)